235 participants
Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-21
- Start Date:
- 2026-09-30
- Completion:
- 2029-09-30
Conditions
- Abemaciclib
- Abemaciclib-related Diarrhea
- Breast Cancer
Interventions
- BIOLOGICAL
- OTHER
No Results Yet